3 Biotech Stocks That Skyrocketed This Week
If you like excitement, biotech stocks provided plenty of it over the last several days. And most of the buzz stemmed from the $11.9 billion buyout of Kite Pharma (NASDAQ: KITE) announced by Gilead Sciences (NASDAQ: GILD) on Monday.
But while Kite Pharma stock shot up nearly 30% on the acquisition news and Gilead stock jumped more than 10%, neither company ranked among the best-performing biotech stocks this week. Instead, three smaller biotechs made even greater leaps -- Abeona Therapeutics (NASDAQ: ABEO), Sangamo Therapeutics (NASDAQ: SGMO), and Juno Therapeutics (NASDAQ: JUNO). Here's why these biotech stocks skyrocketed.
Image source: Getty Images.
Source: Fool.com
Gilead Sciences Inc Stock
€117.26
2.670%
The stock is an absolute favorite of our community with 65 Buy predictions and no Sell predictions.
With a target price of 128 € there is a slightly positive potential of 9.16% for Gilead Sciences Inc compared to the current price of 117.26 €.
